Medpace Holdings, Inc.
General ticker "MEDP" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $14.6B (TTM average)
Medpace Holdings, Inc. follows the US Stock Market performance with the rate: 14.1%.
Estimated limits based on current volatility of 1.5%: low 599.58$, high 617.30$
Factors to consider:
- Total employees count: 6200 (+5.1%) as of 2025
- Top business risk factors: Contract risks, Margin pressure, Regulatory and compliance, Cybersecurity threats, Pandemic risks
- Earnings for 6 months up through Q2 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [413.98$, 576.80$]
- 2026-12-31 to 2027-12-31 estimated range: [441.88$, 612.49$]
Financial Metrics affecting the MEDP estimates:
- Negative: with PPE of 37.2 at the end of fiscal year the price was high
- Positive: 15.80 < Operating profit margin, % of 21.14
- Positive: Industry inventory ratio change (median), % of 0.16 <= 0.47
- Positive: 2.37 < Operating cash flow per share per price, % of 4.35
- Positive: -16.84 < Industry operating profit margin (median), % of -16.21
- Positive: -1.23 < Investing cash flow per share per price, % of -0.19
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: 12.78 < Shareholder equity ratio, % of 23.24 <= 25.20
- Positive: -6.44 < Industry operating cash flow per share per price (median), % of -5.72
Short-term MEDP quotes
Long-term MEDP plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,885.84MM | $2,109.05MM | $2,530.23MM |
| Operating Expenses | $1,549.02MM | $1,662.18MM | $1,995.30MM |
| Operating Income | $336.82MM | $446.87MM | $534.93MM |
| Non-Operating Income | $-1.14MM | $29.05MM | $7.44MM |
| Income(Loss) | $335.68MM | $475.92MM | $542.38MM |
| Taxes | $52.87MM | $71.54MM | $91.25MM |
| Net Income(Loss)* | $282.81MM | $404.39MM | $451.12MM |
| Stockholders Equity | $558.95MM | $825.54MM | $459.07MM |
| Assets | $1,656.83MM | $2,100.87MM | $1,975.47MM |
| Operating Cash Flow | $433.37MM | $608.82MM | $713.22MM |
| Capital expenditure | $36.65MM | $36.55MM | $31.36MM |
| Investing Cash Flow | $-34.63MM | $-28.31MM | $-31.14MM |
| Financing Cash Flow | $-182.64MM | $-154.01MM | $-860.39MM |
| Earnings Per Share** | $9.21 | $13.06 | $15.64 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.